Acute myeloblastic leukaemia in a patient with liver cirrhosis due to chronic hepatitis B during lamivudine therapy

Cilt: 33 Sayı: 1 14 Mart 2011
PDF İndir
EN TR

Acute myeloblastic leukaemia in a patient with liver cirrhosis due to chronic hepatitis B during lamivudine therapy

Abstract

Abstract

There are several causes resulting in decompensation of compensated cirrhosis and disturbing ascites regulation. Besides, hematologic disorders including anemia, thrombocytopenia, leucopenia and coagulation disorders may also accompany cirrhosis. In this case, we discuss a patient with liver cirrhosis on lamivudine treatment with refractory ascites and pancytopenia, who developed acute myeloblastic leukemia during the course of the disease.

Keywords: Hepatitis B, liver cirrhosis, acute myeloblastic leukemia, lamivudine

 

Özet

Kompanze sirozun dekompanze olmasının ve asit regülasyonunun bozulmasının farklı nedenleri vardır. Ayrıca, anemi, trombositopeni, lökopeni ve pıhtılaşma bozuklukları gibi hematolojik bozukluklar da siroza eşlik edebilir. Bu vaka sunumunda, lamivudin kullanan karaciğer sirozlu bir hastada hastalığın seyri sırasında akut miyeloblastik lösemi gelişen refrakter asit ve pansitopenili bir vakayı tartıştık.

Anahtar sözcükler: Hepatit B, karaciğer sirozu, akut myeloblastik lösemi, lamivudine

Keywords

Kaynakça

  1. Doti CA, Gondolesi GE, Sheiner PA, Emre S, Miller CM, Aledort LM. Leukemia after liver transplant. Transplantation 2001; 72: 1643-6.
  2. Yeung LT, Petric M, Cutz E, Roberts EA. Histological improvement with lamivudine therapy for de novo hepatitis B occuring in an anti-HBs-positive child after bone marrow transplantation. Bone Marrow Transplant 2002; 30: 459-62.
  3. Lin PC, Poh SB, Lee MY, Hsiao LT, Chen PM, Chiou TJ. Fatal fulminant hepatitis B after withdrawal of prophylactic lamivudine in hematopoietic stem cell transplantation patients. Int J Hematol 2005; 81: 349-51.
  4. Geoffray A, Shirkhoda A, Wallace S. Abdominal and pelvic computed tomography in leukemic patients. J Comput Assist Tomogr 1984; 8: 857-60.
  5. Simel DL, Weinberg JB. Leukemic ascites complicating acute myelomonoblastic leukemia. Arch Pathol Lab Med 1985; 109: 365-7.
  6. Strittmatter C, Schneider J, Lüthy R, Schmid M. Stenosis of the terminal portal vein branch in acute myeloid leukemia. Schweiz Med Wochenschr 1991; 121: 1298-301.
  7. Fiel I, Strauchen JA, LoValvo R, Meyer RJ, Unger PD. Acute granulocytic leukemia with ascites as the initial manifestation. Acta Cytol 1995; 39: 608-9.
  8. Kojima H, Abei M, Takei N, Mukai Y, Hasegawa Y, lijima T, Nagasawa T. Fatal reactivation of hepatitis B virus following cytotoxic chemotherapy for acute myelogenous leukemia: fibrosing cholestatic hepatitis. Eur J Haematol 2002; 69: 101-4.

Ayrıntılar

Birincil Dil

İngilizce

Konular

-

Bölüm

-

Yazarlar

İlhami Yüksel

Mehmet İbiş

Nurgül Şaşmaz

Yayımlanma Tarihi

14 Mart 2011

Gönderilme Tarihi

17 Nisan 2010

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 2011 Cilt: 33 Sayı: 1

Kaynak Göster

AMA
1.Ataseven H, Yüksel İ, İbiş M, Arhan M, Demir M, Şaşmaz N. Acute myeloblastic leukaemia in a patient with liver cirrhosis due to chronic hepatitis B during lamivudine therapy. CMJ. 2011;33(1):97-100. https://izlik.org/JA69NH64WF